United Therapeutics | UTHR - El Costo De Ventas





El Costo De Ventas Cambio Fecha
Amarin USD 26.05M 1.41M 2025-12
Ardelyx USD 4.81M 6.04M 2026-03
Baxter International USD 1.93B 118M 2026-06
Bayer EUR 4.54B 692M 2026-06
BioCryst Pharmaceuticals USD 3.84M 5.68M 2026-06
Biogen USD 945.1M 147.6M 2026-06
BioMarin Pharmaceutical USD 276.29M 76.8M 2026-06
Emergent BioSolutions USD 381.2M 226.1M 2023-06
Gilead Sciences USD 1000M 445M 2026-06
GlaxoSmithKline GBP 2.07B 192M 2026-06
Halozyme Therapeutics USD 108.68M 67K 2026-06
Insmed USD 69.29M 19.79M 2026-06
Ionis Pharmaceuticals USD 2.74M 261K 2026-06
J&J USD 8B 67M 2026-06
Lexicon Pharmaceuticals USD 201K 191K 2025-12
Moderna USD 93M 862M 2026-06
Omeros USD 33.16M 18.52M 2024-06
Pfizer USD 4.09B 498M 2026-06
PTC Therapeutics USD 39.61M 23.31M 2026-03
Regeneron Pharmaceuticals USD 576.5M 92.9M 2026-06
Sangamo BioSciences 2.42M 1.11M 2024-06
Sarepta Therapeutics USD 150.1M 40.64M 2026-06
Teva Pharmaceutical Industries USD 1.98B 30M 2026-06
United Therapeutics USD 99.5M 33.9M 2026-06
Vertex Pharmaceuticals USD 489.2M 96.4M 2026-06